Alzheimer’s disease (AD) and frontotemporal lobar degeneration (FTLD) account for the vast majority of neurodegenerative dementias. AD and FTLD have different clinical phenotypes with a genetic overlap between them and other dementias.
Objective:
This study aimed to identify the genetic spectrum of sporadic AD and FTLD in the Chinese population.
Methods:
A total of 74 sporadic AD and 29 sporadic FTLD participants were recruited. All participants underwent whole-exome sequencing (WES) and testing for a hexanucleotide expansion in C9orf72 was additionally performed for participants with negative WES results.
Results:
Four known pathogenic or likely pathogenic variants, including PSEN1 (p.G206D), MAPT (p.R5H), LRRK2 (p.W1434*), and CFAP43 (p.C934*), were identified in AD participants, and 1 novel pathogenic variant of ANXA11 (p.D40G) and two known likely pathogenic variants of MAPT (p.D177V) and TARDBP (p.I383V) were identified in FTLD participants. Twenty-four variants of uncertain significance as well as rare variants in risk genes for dementia, such as ABCA7, SORL1, TRPM7, NOS3, MPO, and DCTN1, were also found. Interestingly, several variants in participants with semantic variant primary progressive aphasia were detected. However, no participants with C9orf72 gene variants were found in the FTLD cohort.
Conclusions:
There was a high frequency of genetic variants in Chinese participants with sporadic AD and FTLD and a complex genetic overlap between these two types of dementia and other neurodegenerative diseases.
Van MosseveldeS, EngelborghsS, van der ZeeJ, Van BroeckhovenC (2018) Genotype-phenotype links in frontotemporal lobar degeneration. Nat Rev Neurol14, 363–378.
3.
MiglioreL, CoppedèF (2022) Gene-environment interactions in Alzheimer disease: The emerging role ofepigenetics. Nat Rev Neurol18, 643–660.
4.
FenoglioC, ScarpiniE, SerpenteM, GalimbertiD (2018) Role of genetics and epigenetics in the pathogenesis of Alzheimer’s disease and frontotemporal dementia. . J Alzheimers Dis62, 913–932.
5.
BettensK, SleegersK, Van BroeckhovenC (2013) Genetic insights in Alzheimer’s disease . Lancet Neurol12, 92–104.
6.
RosenbergRN, Lambracht-WashingtonD, YuG, XiaW (2016) Genomics of Alzheimer disease: A review . JAMA Neurol73, 867–874.
7.
KoriathC, LashleyT, TaylorW, DruyehR, DimitriadisA, DenningN, WilliamsJ, WarrenJD, FoxNC, SchottJM, RoweJB, CollingeJ, RohrerJD, MeadS (2019) ApoE4 lowers age at onset in patients with frontotemporal dementia and tauopathy independent of amyloid-βcopathology. . Alzheimers Dement (Amst)11, 277–280.
8.
FerrariR, HernandezDG, NallsMA, RohrerJD, RamasamyA, KwokJB, Dobson-StoneC, BrooksWS, SchofieldPR, HallidayGM, et al. (2014) Frontotemporal dementia and its subtypes: A genome-wide association study. Lancet Neurol13, 686–699.
9.
KoriathC, KennyJ, AdamsonG, DruyehR, TaylorW, BeckJ, QuinnL, MokTH, DimitriadisA, NorsworthyP, BassN, CarterJ, WalkerZ, KippsC, CoulthardE, PolkeJM, Bernal-QuirosM, DenningN, ThomasR, RaybouldR, WilliamsJ, MummeryCJ, WildEJ, HouldenH, TabriziSJ, RossorMN, HummerichH, WarrenJD, RoweJB, RohrerJD, SchottJM, FoxNC, CollingeJ, MeadS (2020) Predictors for a dementia gene mutation based on gene-panel next-generation sequencing of a large dementia referral series. Mol Psychiatry25, 3399–3412.
10.
ZhangK, LiuQ, LiuK, ShenD, TaiH, ShuS, DingQ, FuH, LiuS, WangZ, LiX, LiuM, ZhangX, CuiL (2018) ANXA11 mutations prevail in Chinese ALS patients with and without cognitive dementia. Neurol Genet4, e237.
11.
MaL, ZhangJ, ShiY, WangW, RenZ, XiaM, ZhangY, YangM (2019) Gene mutations in a Han Chinese Alzheimer’s disease cohort. Brain Behav9, e01180.
12.
TanCC, WanY, TanMS, ZhangW, WangZX, SunFR, MiaoD, TanL, YuJT (2016) Association of frontotemporal dementia GWAS loci with late-onset Alzheimer’s disease in a Northern Han Chinese population. J Alzheimers Dis52, 43–50.
13.
HsuJL, LinCH, ChenPL, LinKJ, ChenTF (2021) Genetic study of young-onset dementia using targeted gene panel sequencing in Taiwan. Am J Med Genet B Neuropsychiatr Genet186, 67–76.
GoldmanJS, FarmerJM, WoodEM, JohnsonJK, BoxerA, NeuhausJ, Lomen-HoerthC, WilhelmsenKC, LeeVM, GrossmanM, MillerBL (2005) Comparison of family histories in FTLD subtypes and related tauopathies. Neurology65, 1817–1819.
18.
ZhangN, ZhangL, LiY, GordonML, CaiL, WangY, XingM, ChengY (2017) Urine AD7c-NTP predicts amyloid deposition and symptom of agitation in patients with Alzheimer’s disease and mild cognitive impairment. J Alzheimers Dis60, 87–95.
19.
RichardsS, AzizN, BaleS, BickD, DasS, Gastier-FosterJ, GrodyWW, HegdeM, LyonE, SpectorE, VoelkerdingK, RehmHL (2015) Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med17, 405–424.
20.
RiggsER, AndersenEF, CherryAM, KantarciS, KearneyH, PatelA, RacaG, RitterDI, SouthST, ThorlandEC, Pineda-AlvarezD, AradhyaS, MartinCL (2020) Technical standards for the interpretation and reporting of constitutional copy-number variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med22, 245–257.
Abou TayounAN, PesaranT, DiStefanoMT, OzaA, RehmHL, BieseckerLG, HarrisonSM (2018) Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat39, 1517–1524.
ShiZ, LiuS, XiangL, WangY, LiuM, LiuS, HanT, ZhouY, WangJ, CaiL, GaoS, JiY (2016) Frontotemporal dementia-related gene mutations in clinical dementia patients from a Chinese population. J Hum Genet61, 1003–1008.
25.
CheXQ, ZhaoQH, HuangY, LiX, RenRJ, ChenSD, WangG, GuoQH (2017) Genetic features of MAPT, GRN, C9orf72 and CHCHD10 gene mutations in Chinese patients with frontotemporal dementia. Curr Alzheimer Res14, 1102–1108.
26.
RamosEM, DokuruDR, Van BerloV, WojtaK, WangQ, HuangAY, DeverasettyS, QinY, van BlitterswijkM, JacksonJ, ApplebyB, BordelonY, BrannellyP, BrushaberDE, DickersonB, DickinsonS, Domoto-ReillyK, FaberK, FieldsJ, FongJ, ForoudT, ForsbergLK, GavrilovaR, GhoshalN, GoldmanJ, Graff-RadfordJ, Graff-RadfordN, GrantI, GrossmanM, HeuerHW, HsiungGR, HueyE, IrwinD, KantarciK, KarydasA, KauferD, KerwinD, KnopmanD, KornakJ, KramerJH, KremersW, KukullW, LitvanI, LjubenkovP, LunguC, MackenzieI, MendezMF, MillerBL, OnyikeC, PantelyatA, PearlmanR, PetrucelliL, PotterM, RankinKP, RascovskyK, RobersonED, RogalskiE, ShawL, SyrjanenJ, TartagliaMC, TattonN, TaylorJ, TogaA, TrojanowskiJQ, WeintraubS, WongB, WszolekZ, RademakersR, BoeveBF, RosenHJ, BoxerAL, CoppolaG (2020) Genetic screening of a large series of North American sporadic and familial frontotemporal dementia cases. Alzheimers Dement16, 118–130.
27.
WangJC, AlinaghiS, TafakhoriA, SikoraE, AzconaLJ, KarkheiranS, GoateA, Paisán-RuizC, DarvishH (2018) Genetic screening in two Iranian families with early-onset Alzheimer’s disease identified a novel PSEN1 mutation. Neurobiol Aging62, 244.e215–244.e217.
28.
RyanNS, NicholasJM, WestonPSJ, LiangY, LashleyT, GuerreiroR, AdamsonG, KennyJ, BeckJ, Chavez-GutierrezL, de StrooperB, ReveszT, HoltonJ, MeadS, RossorMN, FoxNC (2016) Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: A case series. Lancet Neurol15, 1326–1335.
29.
LinCH, ChenPL, TaiCH, LinHI, ChenCS, ChenML, WuRM (2019) A clinical and genetic study of early-onset and familial parkinsonism in Taiwan: An integrated approach combining gene dosage analysis and next-generation sequencing. Mov Disord34, 506–515.
CoppolaG, ChinnathambiS, LeeJJ, DombroskiBA, BakerMC, Soto-OrtolazaAI, LeeSE, KleinE, HuangAY, SearsR, LaneJR, KarydasAM, KenetRO, BiernatJ, WangLS, CotmanCW, DecarliCS, LeveyAI, RingmanJM, MendezMF, ChuiHC, Le BerI, BriceA, LuptonMK, PrezaE, LovestoneS, PowellJ, Graff-RadfordN, PetersenRC, BoeveBF, LippaCF, BigioEH, MackenzieI, FingerE, KerteszA, CaselliRJ, GearingM, JuncosJL, GhettiB, SpinaS, BordelonYM, TourtellotteWW, FroschMP, VonsattelJP, ZarowC, BeachTG, AlbinRL, LiebermanAP, LeeVM, TrojanowskiJQ, Van DeerlinVM, BirdTD, GalaskoDR, MasliahE, WhiteCL, TroncosoJC, HannequinD, BoxerAL, GeschwindMD, KumarS, MandelkowEM, WszolekZK, UittiRJ, DicksonDW, HainesJL, MayeuxR, Pericak-VanceMA, FarrerLA, RossOA, RademakersR, SchellenbergGD, MillerBL, MandelkowE, GeschwindDH (2012) Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer’s diseases. Hum Mol Genet21, 3500–3512.
32.
GiauVV, SenanarongV, BagyinszkyE, AnSSA, KimS (2019) Analysis of 50 neurodegenerative genes in clinically diagnosed early-onset Alzheimer’s disease. Int J Mol Sci20, 1514.
33.
ZhuXC, CaoL, TanMS, JiangT, WangHF, LuH, TanCC, ZhangW, TanL, YuJT (2017) Association of Parkinson’s disease GWAS-linked loci with Alzheimer’s disease in Han Chinese. Mol Neurobiol54, 308–318.
BenussiA, PadovaniA, BorroniB (2015) Phenotypic heterogeneity of monogenic frontotemporal dementia. Front Aging Neurosci7, 171.
37.
XuX, SuY, ZouZ, ZhouY, YanJ (2021) Correlation between C9ORF72 mutation and neurodegenerative diseases: A comprehensive review of the literature. Int J Med Sci18, 378–386.
38.
SmithBN, ToppSD, FalliniC, ShibataH, ChenHJ, TroakesC, KingA, TicozziN, KennaKP, Soragia-GkaziA, MillerJW, SatoA, DiasDM, JeonM, VanceC, WongCH, de MajoM, KattuahW, MitchellJC, ScotterEL, ParkinNW, SappPC, NolanM, NestorPJ, SimpsonM, WealeM, LekM, BaasF, Vianney de JongJM, Ten AsbroekA, RedondoAG, Esteban-PérezJ, TilocaC, VerdeF, DugaS, LeighN, PallH, MorrisonKE, Al-ChalabiA, ShawPJ, KirbyJ, TurnerMR, TalbotK, HardimanO, GlassJD, De BellerocheJ, MakiM, MossSE, MillerC, GelleraC, RattiA, Al-SarrajS, BrownRH, Jr., SilaniV, LandersJE, ShawCE (2017) Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis. Sci Transl Med9, eaad9157.
39.
LiuX, WuC, HeJ, ZhangN, FanD (2019) Two rare variants of the ANXA11 gene identified in Chinese patients with amyotrophic lateral sclerosis. Neurobiol Aging74, 235.e239–235.e212.
40.
Ramos-CampoyO, AntonellA, FalgàsN, BalasaM, Borrego-ÉcijaS, Rodríguez-SantiagoB, DattaD, ArmengolL, Fernández-VillullasG, BoschB, OlivesJ, Muñoz-GarcíaC, CastellvíM, Tort-MerinoA, Sánchez-ValleR, LladóA (2020) Screening of dementia genes by whole-exome sequencing in Spanishpatients with early-onset dementia: Likely pathogenic, uncertain significance and risk variants. NeurobiolAging93, e1–e9.
41.
XuY, LiuX, ShenJ, TianW, FangR, LiB, MaJ, CaoL, ChenS, LiG, TangH (2018) The whole exome sequencing clarifies the genotype- phenotype correlations in patients with early-onset dementia. Aging Dis9, 696–705.
RamosEM, DokuruDR, Van BerloV, WojtaK, WangQ, HuangAY, MillerZA, KarydasAM, BigioEH, RogalskiE, WeintraubS, RaderB, MillerBL, Gorno-TempiniML, MesulamMM, CoppolaG (2019) Genetic screen in a large series of patients with primary progressive aphasia. Alzheimers Dement15, 553–560.
44.
CianiM, BonviciniC, ScassellatiC, CarraraM, MajC, FostinelliS, BinettiG, GhidoniR, BenussiL (2019) The missing heritability of sporadic frontotemporal dementia: New insights from rare variants in neurodegenerative candidate genes. Int J Mol Sci20, 3903.
45.
LingH, KaraE, BandopadhyayR, HardyJ, HoltonJ, XiromerisiouG, LeesA, HouldenH, ReveszT (2013) TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. Neurobiol Aging34, 2889e5–9.
